Willkie Farr & Gallagher LLP

07/21/2026 | News release | Distributed by Public on 07/21/2026 09:27

Willkie Advises Growth Equity at Goldman Sachs Alternatives on Series E Investment in Helsing GmbH

Willkie Advises Growth Equity at Goldman Sachs Alternatives on Series E Investment in Helsing GmbH

News

share

July 21, 2026

Willkie advised Growth Equity at Goldman Sachs Alternatives on its investment in Helsing GmbH, Europe's leading defense AI company, as part of a Series E financing round that raised $1.8 billion and values Helsing at $18 billion.

Helsing, based in Germany with operations throughout the European Union, the United Kingdom and North America, provides AI-driven and software-defined defense technology.

Growth Equity at Goldman Sachs Alternatives is an investing platform within Goldman Sachs (NYSE: GS). Goldman Sachs is one of the leading investors in alternatives globally.

The Willkie team was led by partner Miriam Steets and included counsel Dr. Johannes Schmidt and Aurel Hille and associates Dr. Maximilian Schlutz, Denise Klasen and Nils Bock.
Miriam Steets Partner Private Equity
Munich [email protected] +49 89 20304 7509
Dr. Johannes Schmidt Counsel Litigation
Frankfurt [email protected] +49 69 7930 2245
Aurel Hille Counsel Antitrust & Competition
Frankfurt [email protected] +49 69 7930 2145
Dr. Maximilian F. Schlutz Associate Investigations & Enforcement
Denise Klasen Associate Private Equity
Frankfurt [email protected] +49 69 7930 2142
Nils Bock Associate Private Equity
Frankfurt [email protected] +49 69 7930 2288
Willkie Farr & Gallagher LLP published this content on July 21, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 21, 2026 at 15:27 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]